Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 May;7(3):196-202.
doi: 10.1007/s11912-005-0073-2.

Chemoradiotherapy for gastrointestinal cancers

Tyvin A Rich  1 , Christopher Crane, Joshua D Lawson, Jerome Landry
Affiliations
Review

Chemoradiotherapy for gastrointestinal cancers

Tyvin A Rich et al. Curr Oncol Rep. 2005 May.

Abstract

New combinations of chemotherapy with radiotherapy for gastrointestinal cancers are showing evidence that improved outcomes may result from toxicity profiles associated with "targeted" systemic radiosensitizing agents. These new agents are also clinically attractive owing to such factors as oral bioavailability and patient dosing schedules, making them practical and convenient compared with older intravenous administration requirements. Several new classes of radiosensitizing agents are discussed here and underscore aspects of molecular activation in tumors rather than normal tissues because of differences in pathways of metabolism or based on the process of tumor-associated angiogenesis.

PubMed Disclaimer

References

    1. Nat Med. 2001 Sep;7(9):987-9 - PubMed
    1. Biochem Biophys Res Commun. 1998 Dec 30;253(3):797-803 - PubMed
    1. J Clin Oncol. 2001 Nov 1;19(21):4097-106 - PubMed
    1. Invest New Drugs. 2000 Nov;18(4):343-54 - PubMed
    1. Nat Med. 2004 Feb;10(2):145-7 - PubMed

MeSH terms

Substances

LinkOut - more resources